FMS Projected Dividend Yield

Sponsored ADR Repstg Shs/Fresenius Medical Care AG (New) ( NYSE : FMS )

Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Co., which is a kidney dialysis institute. Co. provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. Co. also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products.

11 YEAR PERFORMANCE RESULTS

FMS Dividend History Detail
FMS Dividend News
FMS Competitors News
# of Shares: 0 Closing Price: 27.51 Current Market Value: 0.00 Cost Basis: 0.00 Date Acquired:
Dividend Cash Flow
Year Annual Dividend Dividend Growth # of Shares Annual Dividend Income Yield On Cost %
2024 0.44 0% 0 $ 0.00 0.00%
2025 0.57 0% 0 $ 0.00 2.07%
2026 0.57 0% 0 $ 0.00 2.07%
2027 0.57 0% 0 $ 0.00 2.07%
2028 0.57 0% 0 $ 0.00 2.07%
2029 0.57 0% 0 $ 0.00 2.07%
2030 0.57 0% 0 $ 0.00 2.07%
2031 0.57 0% 0 $ 0.00 2.07%
2032 0.57 0% 0 $ 0.00 2.07%
2033 0.57 0% 0 $ 0.00 2.07%
2034 0.57 0% 0 $ 0.00 2.07%
2035 0.57 0% 0 $ 0.00 2.07%
Using the current years Dividend Growth rate of 0% and projecting 0% forward the annual dividend income in 10yrs would be $ 0.00 with a yield on cost % of 2.07%
Rolling Last 4 qtrs dividends total $ 0.57 and Previous last 4 qtrs dividends total $ 0.44
Dividend 1 Yr Growth = ( 0.57 – 0.44 ) × 100 = 0% (Click the Edit pencil if you want to modify the forward dividend growth rate projection)
0.44
Year
Declaration Date
Ex-Dividend Date
Record Date
Payable Date
Dividend $ Amount
2025
N/A
May 23, 2025
May 23, 2025
Jun 06, 2025
0.5700
2025 Total:
0.5700
2024
N/A
May 17, 2024
May 20, 2024
Jun 03, 2024
0.4433
2024 Total:
0.4433
X
Search Dividend Investor